CADL

Candel Therapeutics (CADL)

About Candel Therapeutics (CADL)

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Details

Daily high

$5.95

Daily low

$5.38

Price at open

$5.46

52 Week High

$13.68

52 Week Low

$4.25

Market cap

290.4M

Dividend yield

0.00%

Volume

734,219

Avg. volume

741,506

P/E ratio

-9.46

Candel Therapeutics News